Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer ...

He feels the company has a sensible strategy to regain its footing somewhat after the years of the COVID-19 pandemic when Comirnaty (co-developed with German peer BioNTech) was a vaccine used to ...

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it's estimated COVID shots have ...

According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...

new product launches and newly acquired products from Seagen offset an expected drop in revenues from its COVID-19 vaccine Comirnaty. Sales of key drugs Xeljanz and Ibrance declined in the quarter.